HOME >> BIOLOGY >> NEWS
SHRO signs agreement with Temple to continue biomedical research

The Sbarro Health Research Organization (SHRO) has reached an agreement with Temple University to continue funding the Sbarro Institute for Cancer Research and Molecular Medicine in Temple's College of Science and Technology (CST).

The agreement, which went into effect March 1, will collectively bring in more than $1 million in support for the Sbarro Institute, located on the Temple main campus in the Biology-Life Sciences building.

SHRO is an independent charitable organization that was founded in 1993 by Antonio Giordano, M.D., Ph.D. and Mario Sbarro, owner of the international restaurant chain Sbarro's. SHRO (http://www.shro.org) originally entered into a three-year partnership with Temple in 2002 to fund the Sbarro Institute.

"I'm very excited about the continuation of this partnership between Sbarro and Temple," said Giordano, director of the Sbarro Institute, who also is a professor of biology and co-director of the Center for Biotechnology at Temple. "The first three years at Temple were exceptional in terms of working with my colleagues at the University and the administration's support in promoting our efforts in biomedical research."

Under the new agreement, the Sbarro Institute will expand its research enterprise with the launch of a new program in molecular therapeutics. The program will be headed by the Sbarro Institute's Pier Paolo Claudio, M.D., Ph.D., an associate professor of biology and a member of the Center for Biotechnology.

"Our vision is to develop novel therapeutic approaches to combat a wide range of human diseases by taking advantage of the insights of bench top research and translating molecular genetic techniques to the patients' bedsides," Claudio said.

The molecular therapeutics program is the second new program to be launched by the Sbarro Institute within the past six months. Eva Surmacz, Ph.D., who joined Temple in November as an associate professor
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
7-Jun-2005


Page: 1 2

Related biology news :

1. Rove beetles act as warning signs for clear-cutting consequences
2. Subtle signs can help predict Huntingtons disease early
3. Delft University of Technology designs language development toy for autistic children
4. Medieval Islamic designs reveal breakthrough in tiled pattern-making
5. Simple diagnostic test detects genetic signs of lung cancer in a patients sputum
6. MIT designs portable lab on a chip
7. Engineer designs system to put wastewater to work
8. Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes
9. Damaged Iraq marshes show renewed signs of life
10. Harvard Medical signs agreement with Merck to develop potential therapy for macular degeneration
11. Why are letters and other human visual signs shaped the way that they are?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2019)... FRANCISCO (PRWEB) , ... February 04, 2019 , ... ... of a new Explorer™ story which provides insights to help individuals understand how ... to decreased cardiovascular wellness. , After individuals eat foods that contain choline ...
(Date:2/2/2019)... ... February 01, 2019 , ... uBiome, ... Testing Laboratories by A2LA, which establishes requirements for medical laboratories to demonstrate competence ... is already CLIA-licensed as well as College of American Pathologists (CAP)-accredited, a designation ...
(Date:1/24/2019)... ... 23, 2019 , ... rHEALTH LLC, an innovative digital health ... the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. ... This application covers the addition of a length scale to hydrogel microparticles. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 15, 2019 , ... Personalized treatment plans may extend life expectancy for early-stage ... new study published in the journal Radiology. , Kidney, or renal, tumors are ... surgical procedure in which the tumor and part of the kidney are removed. However, ...
(Date:1/11/2019)... ... 11, 2019 , ... Drawing on over 22 years of software development expertise, ... EST will explore some of the key lessons that have driven customer satisfaction with ... multiple vendors, and find out how to ensure that you continue to be able ...
(Date:1/10/2019)... (PRWEB) , ... January 08, 2019 , ... VGI Medical ... has become a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin ... the facet joint by utilizing a unique patented dual geometric design to limit motion ...
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
Breaking Biology Technology:
Cached News: